Krishna Susarla S, Jahagirdar R, Ghosh Uttam K, Srikanth Bhatt S, et al. Immunogenicity and safety of Mebella vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study. Vaccine 2023 Aug 31:S0264-410X(23)01021-6. doi: 10.1016/j.vaccine.2023.
PMID: 37659893